-- Creative BioMart, one of the leading biotech supplier of quality protein products and manufacturing techniques, has announced upgrade to its phage display platform, delivering breakthroughs in library diversity, screening technology, dual evolution systems and R&D efficiency.
Phage display is a key method for directed evolution and protein engineering. By connecting phenotype and genotype via bacteriophage display systems, it is possible to select peptides, proteins, and antibodies with extremely specific binding properties.
Leveraging years of accumulated technical expertise and aligning with current trends in phage display, Creative BioMart has undertaken a comprehensive, end-to-end technical upgrade of its platform. This initiative has resulted in a holistic enhancement of the platform's adaptability, screening efficiency, and the reliability of its results.
Now, the upgraded platform has stably enhanced the diversity of its proprietary phage display libraries to 1010 unique sequences. Concurrently, the core M13 pIII peptide display system has undergone deep optimization to bolster the display efficiency and binding fidelity of exogenous proteins, accommodating diverse display requirements—including antibody fragments (scFv, Fab, VHH), random peptides, and enzymes. Paired with multi-dimensional verification assays (ELISA, SPR, BLI), the platform assesses candidate specificity and affinity through standardized testing.
In terms of evolutionary strategies and functional optimization, the platform has further enhanced the synergistic capabilities of its dual in vitro and in vivo evolutionary system. The upgraded platform seamlessly integrates the entire R&D chain—spanning from initial consultation and solution design, library construction, and display system setup, through high-throughput screening, cloning, sequencing, and amplification, to protein expression, purification, and functional characterization—thereby enabling the complete development process from target to functional molecule to be executed entirely in-house, without the need for third-party involvement.
"By expanding library diversity, integrating automated high-throughput screening and unifying dual evolution systems, we aim to support more efficient discovery of antibodies, functional proteins and targeted biotherapeutics, helping partners advance their research timelines." commented Linna, the chief marketing staff at Creative BioMart.
To know more detailed information about the updated phage display platform, please visit https://www.creativebiomart.net/phage-display-platform.htm.
Contact Info:
Name: Caroline
Email: Send Email
Organization: Creative BioMart
Website: https://www.creativebiomart.net/
Release ID: 89187236
Google
RSS